miRNA-let7b5p alleviates visceral hypersensitivity by inhibiting the activation of spinal microglial in male IBS-like rats
Molecular Pain · 2026-04 · 22
DOI: 10.1177/17448069261430202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pain, online erschienen am 04.03.2026. Verfasst von Xianhe Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, Pain Research Institute, School of Basic Medical Sciences, Fujian Med…. Hauptthemen laut MEDLINE: MicroRNAs, Microglia, Irritable Bowel Syndrome, Spinal Cord. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: science and technology projects of fujian province, national natural science foundation of china, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Visceral hypersensitivity is a hallmark feature of irritable bowel syndrome (IBS), yet its underlying mechanisms remain incompletely understood. In the present study, we found that miRNA-let7b5p was downregulated in the spinal cord of IBS model rats induced by neonatal colorectal distension. Concurrently, microglia exhibited a shift toward a pro-inflammatory M1 phenotype and selectively engulfed inhibitory synapses, resulting in impaired GABAergic neuronal function and disruption of the excitatory/inhibitory balance. Intrathecal administration of a miRNA-let7b5p agomir suppressed M1-type microglial activation in the spinal cord, reduced pro-inflammatory cytokine levels, and alleviated visceral hypersensitivity, whereas antagomir treatment induced visceral hypersensitivity in control rats. Mechanistically, MAP3K3 was identified as a direct target of miRNA-let7b5p, and its knockdown recapitulated the protective effects conferred by miRNA upregulation. Collectively, these findings demonstrate that miRNA-let7b5p attenuates IBS-associated visceral hypersensitivity by downregulating MAP3K3, thereby inhibiting spinal microglial activation and restoring GABAergic neuronal function. This study provides novel insights into the pathogenesis of IBS-related visceral hypersensitivity and highlights a potential therapeutic target for drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, Pain Research Institute, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian, China.
Förderung
- science and technology projects of fujian province
- national natural science foundation of china
- Natural Science Foundation of Fujian Province
Zitieren
APA
Wu, X., Tang, Y., He, Z., Yang, F., Liu, Y., Zhang, Q., Chen, A., Chen, Y., & Lin, C. (2026). miRNA-let7b5p alleviates visceral hypersensitivity by inhibiting the activation of spinal microglial in male IBS-like rats. Molecular Pain, 22. https://doi.org/10.1177/17448069261430202
Vancouver
Wu X, Tang Y, He Z, Yang F, Liu Y, Zhang Q, et al. miRNA-let7b5p alleviates visceral hypersensitivity by inhibiting the activation of spinal microglial in male IBS-like rats. Molecular Pain. 2026;22. doi:10.1177/17448069261430202
BibTeX
@article{Wu2026,
author = {Wu, Xianhe and Tang, Ying and He, Zhengqing and Yang, Fan and Liu, Yiqian and Zhang, Qianli and Chen, Aiqin and Chen, Yu and Lin, Chun},
title = {miRNA-let7b5p alleviates visceral hypersensitivity by inhibiting the activation of spinal microglial in male IBS-like rats},
journal = {Molecular Pain},
year = {2026},
volume = {22},
doi = {10.1177/17448069261430202}
}
EUVIMED